121 related articles for article (PubMed ID: 15339302)
1. Two-phase sampling for simultaneous prevalence estimation and case detection.
McNamee R
Biometrics; 2004 Sep; 60(3):783-92. PubMed ID: 15339302
[TBL] [Abstract][Full Text] [Related]
2. Optimal designs of two-stage studies for estimation of sensitivity, specificity and positive predictive value.
McNamee R
Stat Med; 2002 Dec; 21(23):3609-25. PubMed ID: 12436459
[TBL] [Abstract][Full Text] [Related]
3. Designing 2-phase prevalence studies in the absence of a "gold standard" test.
Salim A; Welsh AH
Am J Epidemiol; 2009 Aug; 170(3):369-78. PubMed ID: 19505999
[TBL] [Abstract][Full Text] [Related]
4. Estimating disease prevalence in two-phase studies.
Alonzo TA; Pepe MS; Lumley T
Biostatistics; 2003 Apr; 4(2):313-26. PubMed ID: 12925524
[TBL] [Abstract][Full Text] [Related]
5. Attributable risk estimation from matched case-control data.
Kuritz SJ; Landis JR
Biometrics; 1988 Jun; 44(2):355-67. PubMed ID: 3390504
[TBL] [Abstract][Full Text] [Related]
6. Designs for synthetic case-control studies in open cohorts.
Robins JM; Prentice RL; Blevins D
Biometrics; 1989 Dec; 45(4):1103-16. PubMed ID: 2611319
[TBL] [Abstract][Full Text] [Related]
7. A sequential design to estimate sensitivity and specificity of a diagnostic or screening test.
Wruck LM; Yiannoutsos CT; Hughes MD
Stat Med; 2006 Oct; 25(20):3458-73. PubMed ID: 16374904
[TBL] [Abstract][Full Text] [Related]
8. Estimating the generalized impact fraction from case-control data.
Drescher K; Becher H
Biometrics; 1997 Sep; 53(3):1170-6. PubMed ID: 9290235
[TBL] [Abstract][Full Text] [Related]
9. Improved procedures for estimation of disease prevalence using ranked set sampling.
Chen H; Stasny EA; Wolfe DA
Biom J; 2007 Aug; 49(4):530-8. PubMed ID: 17638284
[TBL] [Abstract][Full Text] [Related]
10. Efficiency of cohort sampling designs: some surprising results.
Langholz B; Thomas DC
Biometrics; 1991 Dec; 47(4):1563-71. PubMed ID: 1786329
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of two-phase designs for prevalence estimation.
McNamee R
Int J Epidemiol; 2003 Dec; 32(6):1072-8. PubMed ID: 14681277
[TBL] [Abstract][Full Text] [Related]
12. On a supplemented case-control design.
Pfeiffer RM; Chatterjee N
Biometrics; 2005 Jun; 61(2):584-90. PubMed ID: 16011708
[TBL] [Abstract][Full Text] [Related]
13. Prospective studies of diagnostic test accuracy when disease prevalence is low.
Obuchowski NA; Zhou XH
Biostatistics; 2002 Dec; 3(4):477-92. PubMed ID: 12933593
[TBL] [Abstract][Full Text] [Related]
14. Likelihood methods for regression models with expensive variables missing by design.
Zhao Y; Lawless JF; McLeish DL
Biom J; 2009 Feb; 51(1):123-36. PubMed ID: 19197954
[TBL] [Abstract][Full Text] [Related]
15. A note on case-control sampling to estimate kappa coefficients.
Kraemer HC; Bloch DA
Biometrics; 1990 Mar; 46(1):49-59. PubMed ID: 2112410
[TBL] [Abstract][Full Text] [Related]
16. General ranked set sampling with cost considerations.
Wang YG; Chen Z; Liu J
Biometrics; 2004 Jun; 60(2):556-61. PubMed ID: 15180686
[TBL] [Abstract][Full Text] [Related]
17. Proportional hazards regression for cancer studies.
Ghosh D
Biometrics; 2008 Mar; 64(1):141-8. PubMed ID: 17573863
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the diagnostic threshold accounting for decision costs and sampling uncertainty.
Skaltsa K; Jover L; Carrasco JL
Biom J; 2010 Oct; 52(5):676-97. PubMed ID: 20976697
[TBL] [Abstract][Full Text] [Related]
19. Extending McNemar's test: estimation and inference when paired binary outcome data are misclassified.
Lyles RH; Williamson JM; Lin HM; Heilig CM
Biometrics; 2005 Mar; 61(1):287-94. PubMed ID: 15737105
[TBL] [Abstract][Full Text] [Related]
20. Variance estimation in clinical studies with interim sample size re-estimation.
Miller F
Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
